Novartis

Novartis CEO Says U.S. Plant Gets FDA Clearance

India Revokes Roche Patent in New Blow for Big Pharma

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

ThromboGenics Says Main Drug Cleared for U.S. Launch

Novartis CEO Keen to Keep Dividend, Big M&A Not Likely

Maturing Belgian Biotechs Outshine European Peers

The European Pharmaceuticals Economy at Halftime 2012

Topics • Technology

Stick to Your Strengths with Biosimilars

Showdown for Big Pharma in India's Highest Court

Novartis Drug Afinitor Gets EU Nod for Breast Cancer

U.S. Health Advisers Back Two New Eye Treatments

EU Crisis Piles on Pain for Europe's Drugmakers

Biogen Q2 Profit Up on MS Drug Sales

Novartis on Track despite Bigger Dollar Hit

US Top Court Rules for Glaxo on Overtime Pay

Stada to Seek Deals as Sector Consolidates

Watson, Actavis to Unveil Deal

EU Supports Novartis MS Pill with Stronger Warning

Chasing Cheaper Cancer Drugs

Bayer Sounds Out Debt Market with Eye On Deals

AstraZeneca, Novartis and Sanofi Douse Hopes For New Drugs

Global Pharma to Pump Cash Into Russia

Lonza Sees Growth on Pharma Outsourcing

Novartis Expects Annual Cost Synergies of $350 Million From Alcon Integration

Novartis Posts Higher Q2 Profit

Bayer Loses European Patent For Yasmin

Bidders Emerge For Gen-Probe, Phadia

Pressure On Actelion Rises After Asahi Case Decision

Roche Seen Kicking off Q1 Season With Sales Drop

Merck KGaA Eyes Job Cuts at Drugs Unit

Novartis Eyes Debts, Possible Smaller Buys

Biosimilars Seen as a $3.7 billion Drug Market by 2015

Andre Hoffmann: Roche Will Not Be For Sale

Bayer in U.S. Accused of Discrimination

Roche's Strong Pipeline Leaves Shareholders Optimistic

53 more articles

Top-Feature

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Brenntag Downsizes Management Board, Retains Both Divisions

Leading Transformation

Easyfairs Deutschland GmbH

Leading the way. Driving results.

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Dow Chemical Company

Anchored in Sustainability

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Interview

Driving Sustainability Through Collaboration

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.